Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin S. Rhee
Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (FTC/TAF) vs. Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by Third Agent of a Randomized, Double-Blind, Active-Controlled Phase 3 Trial
HIV Clinical Trials
Related publications
Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
O015 Establishment of a Monitoring Service for Men Who Have Sex With Men (MSM) Taking Generic Co-Formulated Tenofovir Disoproxil Fumarate (TDF)/emtricitabine (FTC) as Pre-Exposure Prophylaxis (PrEP) Against HIV Infection
Sexually Transmitted Infections
Dermatology
Infectious Diseases
A Phase 1 Randomized Placebo-Controlled Safety and Pharmacokinetic Trial of a Tenofovir Disoproxil Fumarate Vaginal Ring
AIDS
Infectious Diseases
Allergy
Immunology
A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide
Journal of the International Association of Providers of AIDS Care
Dermatology
Infectious Diseases
Immunology
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
PLoS ONE
Multidisciplinary
First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir With Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Is Tenofovir/Emtricitabine Teratogenic?
Therapeutic Advances in Drug Safety
Pharmacology
